Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 126

1.

Rapid Decline of Fasting Glucose in HCV Diabetic Patients Treated with Direct Acting Antiviral Agents.

Pavone P, Tieghi T, d'Ettorre G, Lichtner M, Marocco R, Mezzaroma I, Passavanti G, Vittozzi P, Mastroianni CM, Vullo V.

Clin Microbiol Infect. 2016 Jan 23. pii: S1198-743X(16)00030-6. doi: 10.1016/j.cmi.2015.12.030. [Epub ahead of print]

PMID:
26812446
2.

Dominant enrichment of phenotypically activated CD38+ HLA-DR+ CD8+ T cells, rather than CD38+ HLA-DR+ CD4+ T cells, in HIV/HCV coinfected patients on antiretroviral therapy.

d'Ettorre G, Ceccarelli G, Serafino S, Giustini N, Cavallari EN, Bianchi L, Pavone P, Bellelli V, Turriziani O, Antonelli G, Stroffolini T, Vullo V.

J Med Virol. 2016 Jan 14. doi: 10.1002/jmv.24475. [Epub ahead of print]

PMID:
26765625
3.

Reduced Plasma Levels of sCD14 and I-FABP in HIV-infected Patients with Mesalazine-treated Ulcerative Colitis.

Michelini Z, Baroncelli S, Fantauzzi A, Pasquale C, Galluzzo CM, Sanchez M, Gatto M, Amici R, Franco M, d'Ettorre G, Fimiani C, Mezzaroma I, Vullo V, Merli M, Palmisano L.

HIV Clin Trials. 2016 Jan 7:1-6. [Epub ahead of print]

PMID:
26739837
4.

HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels.

Di Maio VC, Cento V, Di Paolo D, Aragri M, De Leonardis F, Tontodonati M, Micheli V, Bellocchi MC, Antonucci FP, Bertoli A, Lenci I, Milana M, Gianserra L, Melis M, Di Biagio A, Sarrecchia C, Sarmati L, Landonio S, Francioso S, Lambiase L, Nicolini LA, Marenco S, Nosotti L, Giannelli V, Siciliano M, Romagnoli D, Pellicelli A, Vecchiet J, Magni CF, Babudieri S, Mura MS, Taliani G, Mastroianni C, Vespasiani-Gentilucci U, Romano M, Morisco F, Gasbarrini A, Vullo V, Bruno S, Baiguera C, Pasquazzi C, Tisone G, Picciotto A, Andreoni M, Parruti G, Rizzardini G, Angelico M, Perno CF, Ceccherini-Silberstein F; HCV Italian Resistance Network Study Group.

J Antimicrob Chemother. 2016 Mar;71(3):739-50. doi: 10.1093/jac/dkv403. Epub 2015 Dec 17.

PMID:
26679249
5.

ISG15 expression correlates with HIV-1 viral load and with factors regulating T cell response.

Scagnolari C, Monteleone K, Selvaggi C, Pierangeli A, D'Ettorre G, Mezzaroma I, Turriziani O, Gentile M, Vullo V, Antonelli G.

Immunobiology. 2016 Feb;221(2):282-90. doi: 10.1016/j.imbio.2015.10.007. Epub 2015 Oct 30.

PMID:
26563749
6.

An epidemiological investigation to reconstruct a probable human immunodeficiency virus-1 transmission network: a case report.

Serafino S, Cella E, Montagna C, Cavallari EN, Vittozzi P, Lo Presti A, Giovanetti M, Mazzuti L, Turriziani O, Ceccarelli G, d'Ettorre G, Vullo V, Ciccozzi M.

J Med Case Rep. 2015 Nov 3;9:253. doi: 10.1186/s13256-015-0717-2.

7.

State of the Art of Dual Therapy in 2015.

Nozza S, Svicher V, Saracino A, d'Ettorre G, De Luca A, Maggiolo F, Bonora S, di Biagio A, Rusconi S, Mussini C.

AIDS Rev. 2015 Jul-Sep;17(3):127-34.

PMID:
26450801
8.

The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit.

Ceccarelli G, Oliva A, d'Ettorre G, D'Abramo A, Caresta E, Barbara CS, Mascellino MT, Papoff P, Moretti C, Vullo V, Visca P, Venditti M.

BMC Infect Dis. 2015 Sep 30;15:393. doi: 10.1186/s12879-015-1133-3.

9.

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update December 2014.

Antinori A, Marcotullio S, Andreoni M, Ammassari A, d'Arminio Monforte A, Galli M, Girardi E, Mazzotta F, Mussini C, Puoti M, Lazzarin A; Italian HIV Guidelines Working Group.

New Microbiol. 2015 Jul;38(3):299-328. No abstract available.

10.

Reduced risk of Efavirenz Discontinuation in Naïve Patients Starting First-Line Antiretroviral Therapy with Single Tablet versus dual Tablet Regimen.

Fabbiani M, Zaccarelli M, Latini A, Sterrantino G, D'Ettorre G, Grima P, Mondi A, Rossetti B, Borchi B, Giuliani M, Antinori A, De Luca A, Di Giambenedetto S.

HIV Med. 2015 Sep 22. doi: 10.1111/hiv.12313. [Epub ahead of print]

PMID:
26394902
11.

Apoptotic Epitope-Specific CD8+ T Cells and Interferon Signaling Intersect in Chronic Hepatitis C Virus Infection.

Martini H, Citro A, Martire C, D'Ettorre G, Labbadia G, Accapezzato D, Piconese S, De Marzio P, Cavallari EN, Calvo L, Rizzo F, Severa M, Coccia EM, Grazi GL, Di Filippo S, Sidney J, Vullo V, Sette A, Barnaba V.

J Infect Dis. 2016 Feb 15;213(4):674-83. doi: 10.1093/infdis/jiv460. Epub 2015 Sep 19.

PMID:
26386427
12.

Probiotics Reduce Inflammation in Antiretroviral Treated, HIV-Infected Individuals: Results of the "Probio-HIV" Clinical Trial.

d'Ettorre G, Ceccarelli G, Giustini N, Serafino S, Calantone N, De Girolamo G, Bianchi L, Bellelli V, Ascoli-Bartoli T, Marcellini S, Turriziani O, Brenchley JM, Vullo V.

PLoS One. 2015 Sep 16;10(9):e0137200. doi: 10.1371/journal.pone.0137200. eCollection 2015.

13.

Analysis of Th17 and Tc17 Frequencies and Antiviral Defenses in Gut-Associated Lymphoid Tissue of Chronic HIV-1 Positive Patients.

d'Ettorre G, Ceccarelli G, Andreotti M, Selvaggi C, Giustini N, Serafino S, Schietroma I, Nunnari G, Antonelli G, Vullo V, Scagnolari C.

Mediators Inflamm. 2015;2015:395484. doi: 10.1155/2015/395484. Epub 2015 Jun 28.

14.

Thymosin α 1 potentiates the release by CD8(+) cells of soluble factors able to inhibit HIV-1 and human T lymphotropic virus 1 infection in vitro.

Matteucci C, Minutolo A, Pollicita M, Balestrieri E, Grelli S, D'Ettorre G, Vullo V, Bucci I, Luchini A, Aquaro S, Sinibaldi-Vallebona P, Macchi B, Perno CF, Mastino A, Garaci E.

Expert Opin Biol Ther. 2015;15 Suppl 1:S83-100. doi: 10.1517/14712598.2015.1021677. Epub 2015 Jun 22.

PMID:
26094546
15.

Impact of switching from lopinavir/ritonavir to boosted and un-boosted atazanavir on glucose metabolism: ATAzanavir & GLUcose metabolism (ATAGLU) sudy.

d'Ettorre G, Ceccarelli G, Zaccarelli M, Ascoli-Bartoli T, Bianchi L, Bellelli V, De Girolamo G, Serafino S, Giustini N, Mastroianni CM, Vullo V.

Int J STD AIDS. 2015 Jun 10. pii: 0956462415590724. [Epub ahead of print]

PMID:
26068963
16.

HIV Replication at Low Copy Number and its Correlation with the HIV Reservoir: A Clinical Perspective.

Sarmati L, D'Ettorre G, Parisi SG, Andreoni M.

Curr HIV Res. 2015;13(3):250-7. Review.

17.

Healthcare Work and Organizational Interventions to Prevent Work-related Stress in Brindisi, Italy.

d'Ettorre G, Greco M.

Saf Health Work. 2015 Mar;6(1):35-8. doi: 10.1016/j.shaw.2014.10.003. Epub 2014 Oct 18.

18.

MicroRNA-29 family expression and its relation to antiviral immune response and viro-immunological markers in HIV-1-infected patients.

Monteleone K, Selvaggi C, Cacciotti G, Falasca F, Mezzaroma I, D'Ettorre G, Turriziani O, Vullo V, Antonelli G, Scagnolari C.

BMC Infect Dis. 2015 Feb 12;15:51. doi: 10.1186/s12879-015-0768-4.

19.

Mobile phone microbial contamination among neonatal unit healthcare workers.

Orsi GB, Natale F, d'Ettorre G, Protano C, Vullo V, De Curtis M.

Infect Control Hosp Epidemiol. 2015 Apr;36(4):487-9. doi: 10.1017/ice.2015.2. No abstract available.

PMID:
25782910
20.

Dynamics of HIV DNA and residual viremia in patients treated with a raltegravir-containing regimen.

Falasca F, Mazzuti L, DʼEttorre G, Paoletti F, Tripolino O, Serafino S, Antonelli G, Turriziani O.

J Acquir Immune Defic Syndr. 2015 Feb 1;68(2):e18-20. doi: 10.1097/QAI.0000000000000414. No abstract available.

PMID:
25590274
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk